By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

F2G Ltd 

The Manchester Incubator Building
Grafton Street
Manchester    M139XX  United Kingdom
Phone: 44-0-161-606-7250 Fax: 44-0-161-606-7251


SEARCH JOBS


Industry
Biotechnology






Company News
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announced A Major Funding Award From The Technology Strategy Board’s Biomedical Catalyst 9/9/2014 10:06:23 AM
F2G Ltd, The UK-Based Antifungal Drug Discovery And Development Company, Today Announces Commencement Of A Phase 1 Single Ascending Dose Study Of A Novel Antifungal Agent, F901318. 9/2/2014 4:07:07 PM
F2G Ltd and the University of Manchester Announce a New €6.1 Million Project to Develop New Antifungal Agents to Treat Resistant Fungal Infections 6/25/2013 10:14:17 AM
F2G Ltd Appoints Ian Nicholson as CEO 3/18/2013 9:05:45 AM
F2G Ltd Appoints John H. Rex to Board of Directors 2/19/2013 12:36:54 PM
F2G Ltd Raises $30 Million to Fund Pre-Clinical and Clinical Development of Novel Anti-Fungal Compounds 9/5/2012 6:40:47 AM
F2G Ltd Announces the Appointment of Michael R. Hodges, M.D. to the Board of Directors 9/13/2010 2:39:41 PM
F2G Ltd Announces the Appointment of Dr Richard J. White as Chairman of the Board of Directors 2/24/2010 2:19:37 PM
F2G Ltd Initiates Phase I Clinical Trial for FG3622 7/7/2009 10:55:22 AM
F2G Ltd Announces Key Appointment and a Consolidation of the Management Team 2/12/2009 11:59:23 AM
12
//-->